Literature DB >> 29388179

The PCOS Patients differ in Lipid Profile According to their Phenotypes.

Magdalena Spałkowska1, Sandra Mrozińska2, Anna Gałuszka-Bednarczyk3, Katarzyna Gosztyła4, Agnieszka Przywara5, Justyna Guzik6, Marek Janeczko7, Tomasz Milewicz3, Anna Wojas-Pelc1.   

Abstract

Polycystic ovary syndrome (PCOS) affects 4-18% of women of reproductive age. The number of reports exploring the lipid profiles among PCOS patients and number of studied patients are limited. The aim of our study was to assess the lipid profile separately in lean and non-lean women with polycystic ovary syndrome divided according to hyperandrogenemia, defined as free androgen index (FAI)≥5. The second aim was to compare the lipid profiles among lean and non-lean PCOS patients with respect to hyperandrogenemia and regularity of menstruation cycles. We evaluated 232 patients from Department of Endocrinological Gynecology, Jagiellonian University Medical College in Krakow diagnosed with PCOS. The population consisted of 166 lean and 66 non-lean women. We observed higher levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C) in lean patients with FAI<5 than in lean patients with FAI≥5. There were no differences in lipid profile between non-lean patients with FAI≥5 and non-lean patients with FAI<5. Among lean patients higher total cholesterol levels were observed in those with irregular menstruation cycles and FAI<5 than in patients with FAI≥5 and regular cycles. There were no differences in lipid profiles between four phenotypes among non-lean PCOS patients.
CONCLUSIONS: The results of our study showed differences in lipid profile between lean PCOS patients according to their phenotype based on androgens' level. This effect was abandoned by fat tissue mass in non-lean ones. Further studies should be conducted to explore these associations. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29388179     DOI: 10.1055/s-0043-121264

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  3 in total

1.  Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS.

Authors:  Andon Hestiantoro; Putri Deva Karimah; Amalia Shadrina; Budi Wiweko; R Muharam; Brilliant Putri Kusuma Astuti
Journal:  F1000Res       Date:  2019-01-23

2.  Histomorphological Changes in a Rat Model of Polycystic Ovary Syndrome and the Contribution of Stevia Leaf Extract in Modulating the Ovarian Fibrosis, VEGF, and TGF-β Immunoexpressions: Comparison with Metformin.

Authors:  Ahmed A Morsi; Ezat A Mersal; Abdel Razik H Farrag; Ahmed M Abdelmoneim; Alshaymaa M Abdelmenem; Mohamed S Salim
Journal:  Acta Histochem Cytochem       Date:  2022-01-27       Impact factor: 1.938

Review 3.  Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review.

Authors:  Aishwarya Peddemul; Sreedevi Tejovath; Danial Hassan; Khushbu K Patel; Rabia Sikandar; Simranjit S Kahlon; Shaalina Nair; Jihan A Mostafa
Journal:  Cureus       Date:  2022-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.